Bone density and hyperlipidemia: The T-Lymphocyte connection

Journal of Bone and Mineral Research

Volumn 25, Issue 11, 2010, Pages 2460-2469

  Graham, Lucia S ^a   Tintut, Yin ^a   Parhami, Farhad ^a   Kitchen, Christina Mr ^b   Ivanov, Yevgeniv ^a   Tetradis, Sotirios ^c   Effros, Rita B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

cytokines; inflammation; lipids; osteoporosis; T lymphocytes

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE MARROW CELL; BONE MINERAL; C57BL 6 MOUSE; CELL DIFFERENTIATION; COCULTURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIET; HYPERLIPIDEMIA; LIPID DIET; MALE; MORPHOMETRICS; MOUSE; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; BONE DENSITY; BONE MARROW CELLS; CYTOKINES; DIETARY FATS; FEMUR; GENE EXPRESSION REGULATION; HYPERLIPIDEMIAS; INFLAMMATION MEDIATORS; LIPIDS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; OSTEOCLASTS; SCAVENGER RECEPTORS, CLASS E; SPLEEN; T-LYMPHOCYTES; TIBIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78349281472     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.148     Document Type: Article

References (63)

1. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998; 93: 165 -176.
2. Rifas L, Arackal S, Weitzmann MN,. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. J Cell Biochem. 2003; 88: 650 -659.
3. Kong Y-Y, Boyle WJ, Penninger JM,. Osteoprotegerin ligand: a regulator of immune esponses and bone physiology. Immunol Today. 2000; 21: 495 -502.
4. Kotake S, Udagawa N, Hakoda M, et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum. 2001; 44: 1003 -1012.
5. Baker PJ, Howe L, Garneau J, Roopenian DC,. T cell knockout mice have diminished alveolar bone loss after oral infection with Porphyromonas gingivalis. FEMS Immunol Med Microbiol. 2002; 34: 45 -50.
6. Goldring SR, Gravallese EM,. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol. 2000; 12: 195 -199.
7. Bernstein CN, Leslie WD,. The pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol. 2003; 15: 857 -864.
8. Bartold PM, Marshall RI, Haynes DR,. Periodontitis and rheumatoid arthritis: a eview. J Periodontol. 2005; 76 (11 Suppl): 2066 -2074.
9. Libby P,. Inflammation in atherosclerosis. Nature. 2002; 420: 868 -874.
10. Hansson GK, Libby P, Schonbeck U, Yan ZQ,. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res. 2002; 91: 281 -291.
11. McMurray H, Parthasarathy S, Steinberg D,. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest. 1993; 92: 1004 -1008.
12. Zhou X, Robertson AK, Hjerpe C, Hansson GK,. Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler Thromb Vasc Biol. 2006; 26: 864 -870.
13. Caligiuri G, Nicoletti A, Zhou X, Tornberg I, Hansson GK,. Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis. 1999; 145: 301 -308.
14. Geng YJ, Hansson GK,. High endothelial cells of postcapillary venules express the scavenger receptor in human peripheral lymph nodes. Scand J Immunol. 1995; 42: 289 -296.
15. Ohmori R, Momiyama Y, Nagano M, et al. An oxidized low-density lipoprotein receptor gene variant is inversely associated with the severity of coronary artery disease. Clin Cardiol. 2004; 27: 641 -644.
16. Sawamura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997; 386: 73 -77.
17. Hara Y, Kusumi Y, Mitsumata M, Li XK, Fujino M,. Lysophosphatidylcholine upregulates LOX-1, chemokine receptors, and activation-related transcription factors in human T-cell line Jurkat. J Thromb Thrombolysis. 2007.
18. Jie KG, Bots ML, Vermeer C, Witteman JC, Grobbee DE,. Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcif Tissue Int. 1996; 59: 352 -356.
19. Griffith JF, Yeung DK, Antonio GE, et al. Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy. Radiology. 2005; 236: 945 -951.
20. Tintut Y, Morony S, Demer LL,. Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol. 2004; 24: e6 -10.
21. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL,. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res. 2001; 16: 182 -188.
22. Tintut Y, Parhami F, Tsingotjidou A, Tetradis S, Territo M, Demer LL,. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem. 2002; 277: 14221 -14226.
23. Chen JJ, Huang JC, Shirtliff M, et al. CD4 lymphocytes in the blood of HIV(+) individuals migrate rapidly to lymph nodes and bone marrow: support for homing theory of CD4 cell depletion. J Leukoc Biol. 2002; 72: 271 -278.
24. Slifka MK, Whitmire JK, Ahmed R,. Bone marrow contains virus-specific cytotoxic T lymphocytes. Blood. 1997; 90: 2103 -2108.
25. Parretta E, Cassese G, Barba P, Santoni A, Guardiola J, Di Rosa F,. CD8 cell division maintaining cytotoxic memory occurs predominantly in the bone marrow. J Immunol. 2005; 174: 7654 -7664.
26. Zeng D, Hoffmann P, Lan F, Huie P, Higgins J, Strober S,. Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation. Blood. 2002; 99: 1449 -1457.
27. Josien R, Wong BR, Li HL, Steinman RM, Choi Y,. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol. 1999; 162: 2562 -2568.
28. Paigen B, Mitchell D, Reue K, Morrow A, Lusis AJ, LeBoeuf RC,. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc Natl Acad Sci U S A. 1987; 84: 3763 -3767.
29. Paigen B, Morrow A, Brandon C, Mitchell D, Holmes P,. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 1985; 57: 65 -73.
30. Friedewald WT, Levy RI, Fredrickson DS,. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499 -502.
31. Huang MS, Lu J, Ivanov Y, et al. Hyperlipidemia impairs osteoanabolic effects of PTH. J Bone Miner Res. 2008; 23: 1672 -1679.
32. Kitchen CM,. Nonparametric vs parametric tests of location in biomedical research. Am J Ophthalmol. 2009; 147: 571 -572.
33. Kita T, Kume N, Minami M, et al. Role of oxidized LDL in atherosclerosis. Ann N Y Acad Sci. 2001; 947: 199 -205; discussion 205-6.
34. Ross R,. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999; 340: 115 -126.
35. Young IS, McEneny J,. Lipoprotein oxidation and atherosclerosis. Biochem Soc Trans. 2001; 29: 358 -362.
36. Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992; 257: 88 -91.
37. Polzer K, Joosten L, Gasser J, et al. IL-1 is essential for systemic inflammatory bone loss. Ann Rheum Dis. 2009.
38. Graham LS, Parhami F, Tintut Y, Demer LL, Effros RB,. Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss. Clin Immunology. 2009; in press.
39. Di Rosa F, Santoni A,. Bone marrow CD8 T cells are in a different activation state than those in lymphoid periphery. Eur J Immunol. 2002; 32: 1873 -1880.
40. Masopust D, Vezys V, Marzo AL, Lefrancois L,. Preferential localization of effector memory cells in nonlymphoid tissue. Science. 2001; 291: 2413 -2417.
41. Ries WL, Seeds MC, Key LL,. Interleukin-2 stimulates osteoclastic activity: increased acid production and radioactive calcium release. J Periodontal Res. 1989; 24: 242 -246.
42. Parhami F,. Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? Prostaglandins Leukot Essent Fatty Acids. 2003; 68: 373 -378.
43. Rajamannan NM,. Low-density lipoprotein and aortic stenosis. Heart. 2008; 94: 1111 -1112.
44. Udagawa N, Takahashi N, Katagiri T, et al. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med. 1995; 182: 1461 -1468.
45. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL,. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000; 106: 1481 -1488.
46. Zwerina J, Redlich K, Polzer K, et al. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci U S A. 2007; 104: 11742 -11747.
47. Takayanagi H, Ogasawara K, Hida S, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature. 2000; 408: 600 -605.
48. Veys EM, Menkes CJ, Emery P,. A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum. 1997; 40: 62 -68.
49. Sauer AV, Mrak E, Jofra Hernandez R, et al. ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. Blood. 2009.
50. Moriwaki H, Kume N, Kataoka H, et al. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha. FEBS Lett. 1998; 440: 29 -32.
51. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM,. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001; 286: 327 -334.
52. Shih HH, Zhang S, Cao W, et al. CRP is a novel ligand for the oxidized LDL receptor, LOX-1. Am J Physiol Heart Circ Physiol. 2009.
53. Pietschmann P, Grisar J, Thien R, et al. Immune phenotype and intracellular cytokine production of peripheral blood mononuclear cells from postmenopausal patients with osteoporotic fractures. Exp Gerontol. 2001; 36: 1749 -1759.
54. Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD,. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab. 2009; 94: 3387 -3393.
55. Huang JS, Rietschel P, Hadigan CM, Rosenthal DI, Grinspoon S,. Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy. AIDS. 2001; 15: 975 -982.
56. Russell M, Mendes N, Miller KK, et al. Visceral Fat Is a Negative Predictor of Bone Density Measures in Obese Adolescent Girls. J Clin Endocrinol Metab. 2010; 95: 1247 -1255.
57. Lac G, Cavalie H, Ebal E, Michaux O,. Effects of a high fat diet on bone of growing rats. Correlations between visceral fat, adiponectin and bone mass density. Lipids Health Dis. 2008; 7: 16.
58. Spiotta RT, Luma GB,. Evaluating obesity and cardiovascular risk factors in children and adolescents. Am Fam Physician. 2008; 78: 1052 -1058.
59. Parhami F, Morrow AD, Balucan J, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 1997; 17: 680 -687.
60. Hirasawa H, Tanaka S, Sakai A, et al. ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells. J Bone Miner Res. 2007; 22: 1020 -1030.
61. Vinson JA, Proch J, Zubik L,. Phenol antioxidant quantity and quality in foods: cocoa, dark chocolate, and milk chocolate. J Agric Food Chem. 1999; 47: 4821 -4824.
62. van Tits LJ, Demacker PN, de Graaf J, Hak-Lemmers HL, Stalenhoef AF,. alpha-tocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals. Am J Clin Nutr. 2000; 71: 458 -464.
63. Huey KA, Fiscus G, Richwine AF, Johnson RW, Meador BM,. In vivo vitamin E administration attenuates interleukin-6 and interleukin-1beta responses to an acute inflammatory insult in mouse skeletal and cardiac muscle. Exp Physiol. 2008; 93: 1263 -1272.